IBDEI1EQ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22761,0)
 ;;=L94.0^^76^978^20
 ;;^UTILITY(U,$J,358.3,22761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22761,1,3,0)
 ;;=3^Scleroderma,Localized
 ;;^UTILITY(U,$J,358.3,22761,1,4,0)
 ;;=4^L94.0
 ;;^UTILITY(U,$J,358.3,22761,2)
 ;;=^5009470
 ;;^UTILITY(U,$J,358.3,22762,0)
 ;;=D23.9^^76^978^22
 ;;^UTILITY(U,$J,358.3,22762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22762,1,3,0)
 ;;=3^Sebaceous Hyperplasia
 ;;^UTILITY(U,$J,358.3,22762,1,4,0)
 ;;=4^D23.9
 ;;^UTILITY(U,$J,358.3,22762,2)
 ;;=^5002076
 ;;^UTILITY(U,$J,358.3,22763,0)
 ;;=L21.9^^76^978^23
 ;;^UTILITY(U,$J,358.3,22763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22763,1,3,0)
 ;;=3^Seborrhea,Unspec
 ;;^UTILITY(U,$J,358.3,22763,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,22763,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,22764,0)
 ;;=L91.8^^76^978^39
 ;;^UTILITY(U,$J,358.3,22764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22764,1,3,0)
 ;;=3^Skin Tag
 ;;^UTILITY(U,$J,358.3,22764,1,4,0)
 ;;=4^L91.8
 ;;^UTILITY(U,$J,358.3,22764,2)
 ;;=^5009460
 ;;^UTILITY(U,$J,358.3,22765,0)
 ;;=I83.12^^76^978^42
 ;;^UTILITY(U,$J,358.3,22765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22765,1,3,0)
 ;;=3^Stasis Dermatitis,Left Leg
 ;;^UTILITY(U,$J,358.3,22765,1,4,0)
 ;;=4^I83.12
 ;;^UTILITY(U,$J,358.3,22765,2)
 ;;=^5007989
 ;;^UTILITY(U,$J,358.3,22766,0)
 ;;=I83.11^^76^978^43
 ;;^UTILITY(U,$J,358.3,22766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22766,1,3,0)
 ;;=3^Stasis Dermatitis,Right Leg
 ;;^UTILITY(U,$J,358.3,22766,1,4,0)
 ;;=4^I83.11
 ;;^UTILITY(U,$J,358.3,22766,2)
 ;;=^5007988
 ;;^UTILITY(U,$J,358.3,22767,0)
 ;;=C84.19^^76^978^26
 ;;^UTILITY(U,$J,358.3,22767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22767,1,3,0)
 ;;=3^Sezary Disease,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22767,1,4,0)
 ;;=4^C84.19
 ;;^UTILITY(U,$J,358.3,22767,2)
 ;;=^5001640
 ;;^UTILITY(U,$J,358.3,22768,0)
 ;;=C84.13^^76^978^29
 ;;^UTILITY(U,$J,358.3,22768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22768,1,3,0)
 ;;=3^Sezary Disease,Intra-Abdominal Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22768,1,4,0)
 ;;=4^C84.13
 ;;^UTILITY(U,$J,358.3,22768,2)
 ;;=^5001634
 ;;^UTILITY(U,$J,358.3,22769,0)
 ;;=C84.16^^76^978^30
 ;;^UTILITY(U,$J,358.3,22769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22769,1,3,0)
 ;;=3^Sezary Disease,Intrapelvic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22769,1,4,0)
 ;;=4^C84.16
 ;;^UTILITY(U,$J,358.3,22769,2)
 ;;=^5001637
 ;;^UTILITY(U,$J,358.3,22770,0)
 ;;=C84.12^^76^978^31
 ;;^UTILITY(U,$J,358.3,22770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22770,1,3,0)
 ;;=3^Sezary Disease,Intrathoracic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22770,1,4,0)
 ;;=4^C84.12
 ;;^UTILITY(U,$J,358.3,22770,2)
 ;;=^5001633
 ;;^UTILITY(U,$J,358.3,22771,0)
 ;;=C84.14^^76^978^25
 ;;^UTILITY(U,$J,358.3,22771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22771,1,3,0)
 ;;=3^Sezary Disease,Axilla/Upper Limb Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22771,1,4,0)
 ;;=4^C84.14
 ;;^UTILITY(U,$J,358.3,22771,2)
 ;;=^5001635
 ;;^UTILITY(U,$J,358.3,22772,0)
 ;;=C84.11^^76^978^27
 ;;^UTILITY(U,$J,358.3,22772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22772,1,3,0)
 ;;=3^Sezary Disease,Head/Face/Neck Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22772,1,4,0)
 ;;=4^C84.11
 ;;^UTILITY(U,$J,358.3,22772,2)
 ;;=^5001632
 ;;^UTILITY(U,$J,358.3,22773,0)
 ;;=C84.15^^76^978^28
 ;;^UTILITY(U,$J,358.3,22773,1,0)
 ;;=^358.31IA^4^2
